Asylia Diagnostics ^Company

Asylia Diagnostics is a diagnostics technology platform that focuses on precision medicine for immunotherapies. Their main goal is to provide safer and more effective treatments for cancer patients. They collect molecular and real-world evidence data from patients in clinical trials and standard care, and use AI-powered technology to identify specific biomarkers and drug targets. This allows them to develop patient stratification strategies and therapeutic products in collaboration with biopharma and IVD partners. Asylia Diagnostics aims to revolutionize immunotherapy by leveraging data and technology to improve patient outcomes.